VRAX

NASDAQ Healthcare

Virax Biolabs Group Limited - Ordinary Shares

Biotechnology

Virax Biolabs Group Limited, a biotechnology company, focuses on immune response detection, T cell immune profiling, and the development of in vitro diagnostic technologies for viral and immune-mediated diseases in the United Kingdom, the United States, and China. The company offers ViraxImmune, a T cell-based immune profiling and diagnostic platform for post-acute infection syndromes, including long COVID, myalgic encephalomyelitis / chronic fatigue syndrome, and post-treatment Lyme disease. It also provides ImmuneSelect, a research-use-only portfolio of peptide pool ELISpot plates and related immune reagents. In addition, the company is involved in research and development activities and the provision of procurement, warehousing, product development, and staffing management services. It serves research organizations, academic institutions, contract research organizations, biopharmaceutical companies, independent laboratories, and distributors. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was founded in 2013 and is headquartered in Lanarkshire, United Kingdom.

๐Ÿ“Š Market Data
๐ŸŽฏ Investment Strategy Scores

VRAX scores across each investment strategy. Higher is better for that strategy's goals.

High dividend yield + low volatility
High growth potential (high beta + oversold)
Contrarian plays (oversold + below moving average)
Overbought stocks (potential short candidates)
๐Ÿ” Strategy Interpretation

Best fit: ๐Ÿ”ช Falling Knife (98/100) โ€” this strategy Contrarian plays (oversold + below moving average).

Lowest fit among scored strategies: ๐Ÿ’ฐ Dividend Daddy (18/100). No single score is a buy or sell signal โ€” use multiple lenses together. Learn how to read these scores โ†’

Find VRAX in your text

Paste any article, transcript, or post โ€” the tool will extract VRAX and every other hidden ticker.

Try the Ticker Extractor โ†’

Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-07-16.